Hydroxyzine hydrochloride is the dihydrochloride of 1(p-chlorobenzhydryD -4-2-(2-hydrozyethozy) -ethyl -diethylendiamine or structurally:
It is marketed under a trade name of "Atarax", It has been established in the course of laboratory studies (2) that Hydroxyzine possesses tranquilizing properties without being soporific and is, at the same time, a muscular relaxant. Clinically it has been claimed that "Atarax" (Hydroxyzine) relieves "tension", nervous irritability, emotional stress, anguish, anxiety with or without insomnia. The best therapeutic results have been claimed in conditions in which nervous excitation, hyperemotionalism, insomnia, and increased muscular tension are prominent symptoms (1, 4) , In short, this drug has been found to be effective in those patients, mostly psychoneurotic in whom "tension", both psychic and somatic is the prominent symptom.
"Largactil" (Chlorpromazine) is a well-known tranquilizer which produces general sedation, "relaxation", serene feeling of detachment often accompanied by drowsiness.
In this study an attempt was made to evaluate the effect of "Atarax" and the effect of "Largactil" in the states of "tension".
Sample and Method
The subjects were drawn from the newly admitted patients into the male admission ward of the Saskatchewan Hospital, Weyburn, during a period of about one year. The procedure was as follows: if the psychiatrist in charge of the case (the same psychiatrist for all the subjects) decided that "tension" was a prominent feature in the clinical picture, the patient was included in the project. He was rated on a tension scale (described in the following section) by three psychiatrists during a standard interview. (The psychiatrist who saw the patient originally was not one of the raters) . He was then allocated to a prearranged random order to group "A", "B", or "C". Group "A" received "Atarax", group "B" received Placebo, group "C" received "Largactil". The study was "double-blind"; the subjects received tablets from bottles marked "A", "B" and "C", which were not decoded until the end of the project. The dose of the two drugs and the Placebo was the same,-50 mg. four times a day for 14 days. After 14 days the subjects were again rated on the tension scale during the standard interview by the same three raters. During the trial the subjects remained on the same ward, (the samẽ~r d throughout the whole project). There were 36 subjects included in the study, 12 subjects in each group. All of them were male. In group "A" there were 4 undifferentiated, 2 Catatonic, 1 paranoid, 1 simple schizophrenic, 1 paranoid state, 1 acute psychotic episode, 1 reactive depression, 1 phobic reaction. The mean age was 32.3 years (range 25-53). In group "B" there were 5 undifferentiated, 1 catatonic, 3 paranoid schizophrenics, 1 acute schizophrenic reaction, 2 cases of manic-depressive psychosis. The mean age was 31.8 years (range 17-60).
In group "C" there were 4 paranoid, 2 undifferentiated, 1 simple, 1 pseudoneurotic schizophrenic, 2 acute schizophrenic reaction, 1 paranoid state, 1 manic depressive psychosis, 1 immature personality. The mean age was 34.2 years, (range 21-46).
Rating Scale
Like many other psychiatric concepts, "tension" is a very vague and subjective concept. It is used by psychiatrists quite loosely without any attempt to define it. A pilot study with a "tension" scale in which raters rated subjects on over-all "tension" (9 point scale) showed that there was little agreement between the raters and the reliability of the scale was very low. That was in spite of the fact that the three raters were psychiatrists with more or less the same training and orientation. It was decided to devise a scale which rated separately various behaviourly external, manifestations of the so called "tension".
A perusal of standard text books of psychiatry has indicated that most of the authors instruct their readers to look for manifestations of "tension" in 1) movements, 2) posture, 3) facial expression, 4) speech, and 5) signs of autonomic disturbance. Accordingly, a composite scale was constructed which included five 5 point rating scales of the aforementioned areas of behaviour and also an additional 5 point scale. By this last scale the inner experience of the patient was rated on the basis of the emphatic evaluation of his feeling. The scale is reproduced at the end of the paper. (See appendix).
The standard interview was conducted by a senior nursing officer. It ran as follows:
"Would you come in, Mr., or Mrs., or Miss." "Please sit down." "My name is . I don't know whether you know the names of the doctors. . .. This is doctor This is doctor _ This is doctor " "We would like your cooperation in a research project we are carrying out and we would like to ask you a few questions." (Pause) "How long have you been in the hospital?" "How are you feeling now?" "Are you feeling any better here than at home?"
"What do you think of the hospital?" "Thank you, very much, for coming to see us. We shall do everything we can to help you, and I am sure that you will get better very soon. . . . Cheerio for now."
The score of "tension" was the sum of the ratings on the 6 individual scales. The three raters rated the subject at the same time during the standard interview. The reliability of the scale was assessed as follows:
The degree of inter-rater agreement was found by calculating productmoment correlations between scores of the three raters on 72 occasions. The correlations were: .57, .67 and .70. The mean correlation of the three raters' scores was r=.65.
The consistency of the scale was calculated by split-half, "odd-even", reliability measure. In 72 ratings the product moment correlation between the mean scores of the 3 raters on the odd and even items was 1'=.67. When adjusted by the Spearman-Brown prophecy formula the value of the correlation became r=.80.
As far as the validity is concerned the scale has only a "face validity". In view of the fact that the concept of "tension" is so vague and that the ratings of over-all "tension" are so unreliable, establishing of validity for the scale was very difficult. Nevertheless, it would be advisable to validate this scale with some well-'Known anxiety rating scales such as the Taylor Manifest Anxiety Scale, since "tension" and "anxiety" are clinically closely related to each other. Also this scale could be validated against some physiological measurements which are usually related to the state of tension. Electromyographic, polygraphic, P. G. R. (psychoresponse) E. E. G. (electro-encephalograph) or sedation threshold (Shagass 3) measurements could be used for validation purposes.
Results
The mean total score of the 3 raters on the "tension" scale was used as the subject's tension score. The "tension" scores before and after drug trial for the three groups were analyzed by analysis of covariance. The results are summarized in Table 1 and Table 2 . There is a tendency for the groups to score lower on the second rating (after the drug trial), but there is no significant difference between the groups.* Thus neither"Atarax" nor "Largactil" lower significantly "tension", as measured in this study.
In order to assessto the total effect of the drug apart from the specific effect on "tension", the subsequent progress of the patients in the three groups have been followed up. The results are summarized in Table 3 . There is no statistically significant difference between the three groups in any of the criteria used. The Placebo group stayed on the average longer in the hospital, but the difference is not statistically significant.
No side effects were reported.
Discussion
The results are negative. There was no difference in "tension" nor in the final outcome between the drug and the Placebo groups. It must be stressed that this study was concerned with symptomatic relief of "tension" and not with the long term treatment. The subjects selected constituted a heterogenous group from the diagnostic point of view and had only the symptom of "tension" in common.
After the trial was over the subjects in all groups received the usual treatment. Therefore, the results referring to the final outcome are not very relevant as far as the assessment of the drugs is concerned and are included only for the sake of the completeness of the records.
Several explanations could be offered for the negative results as far as "tension" was concerned. The rating scale could have been too crude and lacking in validity. The drugs in the doses used could have been ineffective. Another interesting possibility is that the concept of "tension" is too general. It could refer to a multi-factorial variable. There may be big differences in what is called "tension" in different personalities and different diagnostic categories. For instance, "ten-. sion" in a setting of schizophrenia may be a completely different syndrome from "tension" in a setting of anxiety neurosis, or agitated depression in spite of superficial similarities. As a result, different "tensions" could respond differently to drug therapies. In psychiatry, as in other fields of medicine, symptomatic approach and treatment are inferior to approach and treatment directed as the specific causes of illness.
"It could be argued that parametric statistics are not applicable in this case, because the tension ratings could be interpreted as having been done on an ordinal rather than interval or ratio measurement scale. If a non-parametric statistical test, such as sign test is used there is diminished tension score on second rating in 10 subjects of the "Largactil" group and in 6 subjects of botb Placebo and "Atarax" groups. This difference is not statistically significant. ("couldn't slightly dither". care less") excited. Extremely anxious.
